Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis

Published:2018-04 Issue: Volume:124 Page:21-28
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Di Maio Massimo,Baratelli Chiara,Bironzo Paolo,Vignani Francesca,Bria Emilio,Sperti Elisa,Marcato Maddalena,Roila Fausto

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference24 articles.

1. Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy;Ballatori;Health Qual. Life Outcomes,2003

2. The impact of chemotherapy-induced nausea and vomiting on health-related quality of life;Ballatori;Support. Care Cancer,2007

3. Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors;Di Maio;Anticancer Drugs,2013

4. Assessing the magnitude of antiemetic benefit with the addition of the NK1 receptor antagonist aprepitant for all platinum agents: analysis of 1872 patients in prospective randomized clinical phase III trials;Gralla;J. Clin. Oncol.,2010

5. Acute emesis: moderately emetogenic chemotherapy;Herrstedt;Support. Care Cancer,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial;Journal of Clinical Oncology;2024-09-06

2. Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success;Critical Reviews in Oncology/Hematology;2024-09

3. Fosaprepitant: current options to prevent chemotherapy-induced nausea and vomiting: A review;Journal of Modern Oncology;2023-02-01

4. Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis;Frontiers in Oncology;2022-08-12

5. Cisplatin-Induced Anorexia and Pica Behavior in Rats Enhanced by Chronic Stress Pretreatment;Frontiers in Pharmacology;2022-07-15